The nation of Zimbabwe has turned down a significant US health deal valued at $367m (£272m) over five years due to Washington's request for sensitive biological samples.
The decision was revealed after a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
An official spokesperson has since explained that the US was requesting biological samples for scientific study and profit but refused to guarantee the benefits from future vaccines.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to find a agreement suitable to all parties so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This development follows a comparable situation in Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
After resuming office last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.
As per reports, Sixteen nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information for a long time, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Effectively, our country would supply the raw materials for medical research without any certainty that the end products would be available to our population if a future disease outbreak emerge."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were disrupting frameworks already set up via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.
"We encourage further discussions with our American counterparts on how future collaboration might be arranged in a way that honours the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but urged that negotiations must proceed considering a large portion of the country's HIV programmes were funded by external financing.
"If technical issues exist, including those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," the group added.
The situation emphasises the continuing debate between receiving vital international aid and safeguarding local interests in an ever more interconnected world.